Cargando…
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine
Myocarditis and/or pericarditis have been reported as adverse events following coronavirus disease 2019 (COVID-19) messenger RNA vaccination, with most cases occurring within 1 week after the second dose. We report a rare case of myocarditis after the first dose of the BNT162b2 (Pfizer-BioNTech) COV...
Autores principales: | Park, Seunghwan, You, Jihye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039195/ https://www.ncbi.nlm.nih.gov/pubmed/35470603 http://dx.doi.org/10.3346/jkms.2022.37.e131 |
Ejemplares similares
-
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273
Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022) -
Acute myocarditis after receiving first dose of BNT162b2 mRNA vaccine
por: Wu, Bryan, et al.
Publicado: (2022) -
Fulminant myocarditis after the second dose of COVID‐19 mRNA vaccination
por: Oka, Akihiro, et al.
Publicado: (2022) -
Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021) -
Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)